Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.100 GeneticVariation group BEFREE TSAs were classified into two phenotypes according to their molecular characteristics: microvesicular serrated subtypes with BRAF mutations (SA-1 and -2 lesions) and subtypes containing tubulo-serrated/conventional adenoma with K/NRAS mutations (SA-3 and -4 lesions). 31833094 2019
Entrez Id: 4893
Gene Symbol: NRAS
NRAS
0.070 GeneticVariation group BEFREE TSAs were classified into two phenotypes according to their molecular characteristics: microvesicular serrated subtypes with BRAF mutations (SA-1 and -2 lesions) and subtypes containing tubulo-serrated/conventional adenoma with K/NRAS mutations (SA-3 and -4 lesions). 31833094 2019
Entrez Id: 51660
Gene Symbol: MPC1
MPC1
0.010 Biomarker group BEFREE Moreover, in two distinct CRC mouse models, loss of Mpc1 prior to a tumorigenic stimulus doubled the frequency of adenoma formation and produced higher grade tumors. 31813825 2020
Entrez Id: 116844
Gene Symbol: LRG1
LRG1
0.020 Biomarker group BEFREE Two panels, one consisting of Hp and LRG1 and one of Hp, LRG1, RBP4 and FN1 were identified for high-risk adenomas and CRCs detection (sensitivity of 66 and 62%, respectively, at specificity of 95%). 31784980 2020
Entrez Id: 309
Gene Symbol: ANXA6
ANXA6
0.010 Biomarker group BEFREE A protein panel, consisting of haptoglobin (Hp), LAMP1, SYNE2 and ANXA6, was identified for the detection of high-risk adenomas (sensitivity of 53% at specificity of 95%). 31784980 2020
Entrez Id: 3916
Gene Symbol: LAMP1
LAMP1
0.010 Biomarker group BEFREE A protein panel, consisting of haptoglobin (Hp), LAMP1, SYNE2 and ANXA6, was identified for the detection of high-risk adenomas (sensitivity of 53% at specificity of 95%). 31784980 2020
Entrez Id: 5950
Gene Symbol: RBP4
RBP4
0.010 Biomarker group BEFREE Two panels, one consisting of Hp and LRG1 and one of Hp, LRG1, RBP4 and FN1 were identified for high-risk adenomas and CRCs detection (sensitivity of 66 and 62%, respectively, at specificity of 95%). 31784980 2020
Entrez Id: 3240
Gene Symbol: HP
HP
0.010 Biomarker group BEFREE Two panels, one consisting of Hp and LRG1 and one of Hp, LRG1, RBP4 and FN1 were identified for high-risk adenomas and CRCs detection (sensitivity of 66 and 62%, respectively, at specificity of 95%). 31784980 2020
Entrez Id: 7173
Gene Symbol: TPO
TPO
0.050 Biomarker group BEFREE Significant lowering of TPO was revealed in oncocytic adenomas and papillary carcinomas. 31777257 2020
Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
0.050 Biomarker group BEFREE It could be concluded that N. domestica Thunb. constituents affect both apoptosis and Akt-signaling pathways during the stages of early and intermediate adenoma through interaction with the targets CASP3 and MAPK1 (ErC2) while during the stages of late adenoma and carcinoma, the compounds acts through the p53 and ErbB signaling pathways. 31760157 2020
Entrez Id: 836
Gene Symbol: CASP3
CASP3
0.030 Biomarker group BEFREE It could be concluded that N. domestica Thunb. constituents affect both apoptosis and Akt-signaling pathways during the stages of early and intermediate adenoma through interaction with the targets CASP3 and MAPK1 (ErC2) while during the stages of late adenoma and carcinoma, the compounds acts through the p53 and ErbB signaling pathways. 31760157 2020
Entrez Id: 406991
Gene Symbol: MIR21
MIR21
0.100 Biomarker group BEFREE Our three steps bioinformatics approach identified ABCB1, HPGD, BCL2, TIAM1, TLR3, and PDCD4 as common targets for mir-21 in both of adenoma as well as adenocarcinoma suggesting they are biomarkers for early CRC. 31756546 2020
Entrez Id: 27250
Gene Symbol: PDCD4
PDCD4
0.040 Biomarker group BEFREE Our three steps bioinformatics approach identified ABCB1, HPGD, BCL2, TIAM1, TLR3, and PDCD4 as common targets for mir-21 in both of adenoma as well as adenocarcinoma suggesting they are biomarkers for early CRC. 31756546 2020
Entrez Id: 10859
Gene Symbol: LILRB1
LILRB1
0.020 Biomarker group BEFREE <b>Results:</b> We have found relative overexpression of <i>miR-30e-5p, miR-30d-5p, miR-223-3p</i>, and <i>miR-7-5p</i> in hyperplasia compared to adenoma by next-generation sequencing. 31736877 2019
Entrez Id: 2867
Gene Symbol: FFAR2
FFAR2
0.020 AlteredExpression group BEFREE The analysis of clinical specimens revealed that the expression of GPR43 and GPR109A gradually decreased from human normal colonic tissue to adenoma to carcinoma. 31734354 2020
Entrez Id: 338442
Gene Symbol: HCAR2
HCAR2
0.010 AlteredExpression group BEFREE The analysis of clinical specimens revealed that the expression of GPR43 and GPR109A gradually decreased from human normal colonic tissue to adenoma to carcinoma. 31734354 2020
Entrez Id: 5617
Gene Symbol: PRL
PRL
0.400 AlteredExpression group BEFREE Despite suppression of prolactin levels with cabergoline, the pituitary tumor continued to increase in size and the patient developed clinical symptoms and biochemistry consistent with the diagnosis of acromegaly due to acidophilic stem cell adenoma, an extremely rare subtype of mixed growth hormone/prolactin adenoma, which behaves more aggressively and has a lower surgical cure rate compared to the pure GH-secreting adenoma. 31721135 2019
Entrez Id: 5741
Gene Symbol: PTH
PTH
0.100 AlteredExpression group BEFREE To assess the correlation between parathyroid weight and preoperative parathyroid hormone and calcium levels in patients with primary hyperparathyroidism with a solitary adenoma and determine if these could be used to predict expected parathyroid weight. 31699571 2019
Entrez Id: 4360
Gene Symbol: MRC1
MRC1
0.100 GeneticVariation group BEFREE No significant differences were observed for dMMR/MSI in relation to MMR variants and location of adenomas. 31695176 2020
Entrez Id: 652995
Gene Symbol: UCA1
UCA1
0.010 AlteredExpression group BEFREE Two candidates with the greatest increase in expression in the adenoma-carcinoma transition were further confirmed by qRT-PCR (UCA1, CCAT1) and by ISH (UCA1). 31694571 2019
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.400 GeneticVariation group BEFREE Twenty-five CRC biopsies and 15 adenoma were analyzed for KRAS mutations by DNA sequencing (Sanger sequencing), and all 50 patients (35 CRCs and 15 adenomas) were evaluated by immunohistochemistry for the CR-1 protein expression. 31692030 2020
Entrez Id: 1378
Gene Symbol: CR1
CR1
0.010 AlteredExpression group BEFREE Twenty-five CRC biopsies and 15 adenoma were analyzed for KRAS mutations by DNA sequencing (Sanger sequencing), and all 50 patients (35 CRCs and 15 adenomas) were evaluated by immunohistochemistry for the CR-1 protein expression. 31692030 2020
Entrez Id: 6997
Gene Symbol: TDGF1
TDGF1
0.010 AlteredExpression group BEFREE Twenty-five CRC biopsies and 15 adenoma were analyzed for KRAS mutations by DNA sequencing (Sanger sequencing), and all 50 patients (35 CRCs and 15 adenomas) were evaluated by immunohistochemistry for the CR-1 protein expression. 31692030 2020
Entrez Id: 57817
Gene Symbol: HAMP
HAMP
0.020 Biomarker group BEFREE Deregulation of hepcidin synthesis is associated with anemia in three conditions: iron refractory iron deficiency anemia (IRIDA), the common anemia of acute and chronic inflammatory disorders, and the extremely rare hepcidin-producing adenomas that may develop in the liver of children with an inborn error of glucose metabolism. 31649559 2019
Entrez Id: 2956
Gene Symbol: MSH6
MSH6
0.080 Biomarker group BEFREE All four adenomas showed retention of MLH1, MHS2 and MSH6 but complete loss of PMS2 in both low-grade and high-grade dysplasia areas.Two of the four adenomas were MSI-high, <i>BRAF V600E</i> wild type and were not <i>MLH1</i> methylated. 31649038 2019